Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Carolina Schinke

Concepts (316)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
75
2024
2954
8.580
Why?
Hematopoietic Stem Cell Transplantation
9
2024
567
2.220
Why?
Antibodies, Bispecific
7
2024
69
2.100
Why?
B-Cell Maturation Antigen
8
2024
91
1.740
Why?
Bone Marrow
11
2024
363
1.400
Why?
Leukemia, Plasma Cell
2
2020
33
1.380
Why?
Neoplasms, Plasma Cell
3
2024
37
1.330
Why?
Paraproteinemias
2
2022
72
1.320
Why?
Immunotherapy, Adoptive
6
2024
157
1.220
Why?
Humans
90
2024
50208
1.210
Why?
Monoclonal Gammopathy of Undetermined Significance
4
2024
115
1.190
Why?
Neoplasm, Residual
6
2022
165
1.170
Why?
Immunoglobulin Light Chains
2
2017
82
1.050
Why?
Transplantation, Autologous
10
2024
469
1.030
Why?
Myelodysplastic Syndromes
5
2016
81
0.930
Why?
Immunoconjugates
2
2022
38
0.910
Why?
Mutation
8
2022
1294
0.900
Why?
Antibodies, Monoclonal
6
2023
460
0.830
Why?
Leukemia, Myeloid, Acute
4
2019
185
0.810
Why?
Prognosis
16
2024
1954
0.780
Why?
Gene Expression Regulation, Neoplastic
9
2024
828
0.770
Why?
Health Personnel
1
2024
254
0.770
Why?
Gene Expression Profiling
10
2023
1037
0.760
Why?
Aged
24
2024
9405
0.750
Why?
Testis
1
2021
69
0.730
Why?
Tumor Microenvironment
5
2024
233
0.700
Why?
Hematopoietic Stem Cells
3
2019
184
0.690
Why?
Cell Proliferation
8
2023
1013
0.660
Why?
Clonal Evolution
4
2024
56
0.650
Why?
Gene Expression
3
2018
609
0.640
Why?
Middle Aged
23
2024
12206
0.610
Why?
Male
31
2024
25399
0.600
Why?
Clinical Trials as Topic
6
2023
466
0.580
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2024
990
0.580
Why?
Signal Transduction
5
2024
1622
0.570
Why?
Translocation, Genetic
5
2021
264
0.560
Why?
Thoracic Neoplasms
1
2016
13
0.540
Why?
Plasmacytoma
1
2016
42
0.520
Why?
Receptors, Interleukin-8B
1
2015
4
0.510
Why?
Adult
19
2024
13324
0.500
Why?
Interleukin-8
1
2015
86
0.490
Why?
Plasma Cells
5
2023
223
0.450
Why?
Female
27
2024
26635
0.450
Why?
Receptors, G-Protein-Coupled
2
2024
53
0.450
Why?
Survival Analysis
7
2021
666
0.440
Why?
Antineoplastic Agents
7
2024
1186
0.430
Why?
Combined Modality Therapy
4
2024
636
0.420
Why?
Stem Cell Transplantation
4
2024
182
0.420
Why?
Fluorodeoxyglucose F18
5
2021
194
0.410
Why?
Neutropenia
2
2023
115
0.400
Why?
DNA Methylation
4
2020
550
0.400
Why?
Oncogene Proteins, Fusion
2
2018
58
0.390
Why?
Neoplasms, Second Primary
2
2024
78
0.390
Why?
Chromosomes, Human, Pair 1
3
2023
93
0.380
Why?
Neoplasm Recurrence, Local
7
2024
613
0.380
Why?
Polycomb Repressive Complex 2
2
2021
47
0.380
Why?
Positron-Emission Tomography
4
2022
294
0.370
Why?
Epigenesis, Genetic
4
2020
378
0.370
Why?
Evolution, Molecular
2
2021
99
0.360
Why?
Tretinoin
1
2010
53
0.350
Why?
Aged, 80 and over
8
2024
3154
0.340
Why?
Treatment Outcome
10
2024
5155
0.340
Why?
Risk Assessment
4
2024
1262
0.330
Why?
Immunoglobulin kappa-Chains
2
2021
22
0.320
Why?
Transcription Factors
3
2023
564
0.320
Why?
DNA-Binding Proteins
2
2021
428
0.300
Why?
Neoplasm Proteins
3
2020
324
0.290
Why?
Cell Line, Tumor
6
2024
1416
0.290
Why?
Melanoma
1
2010
290
0.280
Why?
Transcriptome
2
2020
320
0.280
Why?
Disease Progression
7
2023
831
0.270
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
2024
92
0.260
Why?
Biopsy
2
2018
590
0.260
Why?
Radiopharmaceuticals
3
2021
208
0.250
Why?
Skin Neoplasms
1
2010
492
0.240
Why?
Dexamethasone
3
2024
430
0.240
Why?
Chemokine CXCL12
1
2024
32
0.240
Why?
T-Lymphocytes
5
2024
339
0.240
Why?
Kaplan-Meier Estimate
3
2021
465
0.240
Why?
Sialic Acid Binding Ig-like Lectin 2
1
2024
2
0.240
Why?
Antigens, CD19
1
2024
24
0.230
Why?
Mutation Rate
2
2021
36
0.230
Why?
Genome-Wide Association Study
1
2024
166
0.220
Why?
Myeloproliferative Disorders
1
2023
28
0.220
Why?
Cell Cycle
2
2021
232
0.220
Why?
Neoplasm Staging
2
2024
738
0.220
Why?
Proto-Oncogene Proteins B-raf
2
2020
79
0.210
Why?
Drug Resistance, Neoplasm
1
2024
314
0.200
Why?
Genomics
2
2023
285
0.200
Why?
Qualitative Research
1
2024
336
0.200
Why?
Osteolysis
1
2022
75
0.200
Why?
Drug Approval
1
2022
47
0.200
Why?
Waldenstrom Macroglobulinemia
1
2022
40
0.200
Why?
Lymphoma, B-Cell
1
2022
63
0.200
Why?
Polymorphism, Single Nucleotide
1
2024
485
0.200
Why?
Hematologic Diseases
1
2021
22
0.200
Why?
Bone Marrow Transplantation
1
2022
116
0.190
Why?
Epigenomics
1
2021
68
0.190
Why?
Patient Participation
1
2022
66
0.190
Why?
Genetic Predisposition to Disease
1
2024
509
0.190
Why?
Abnormal Karyotype
1
2021
6
0.190
Why?
Chromosome Deletion
2
2023
140
0.190
Why?
Myeloma Proteins
1
2021
24
0.190
Why?
Immunoglobulin A
1
2021
45
0.190
Why?
Drug Design
2
2013
121
0.190
Why?
Diffusion Magnetic Resonance Imaging
2
2019
124
0.190
Why?
Communicable Diseases
1
2021
55
0.190
Why?
Antibodies, Monoclonal, Humanized
1
2022
225
0.190
Why?
Genes, Tumor Suppressor
2
2021
73
0.180
Why?
Hematologic Neoplasms
1
2022
99
0.180
Why?
Gene Expression Regulation, Leukemic
1
2020
33
0.180
Why?
Practice Guidelines as Topic
1
2023
449
0.180
Why?
Salvage Therapy
1
2021
139
0.180
Why?
Immunoglobulin G
1
2021
186
0.180
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.180
Why?
Neoplasm Invasiveness
1
2021
266
0.170
Why?
Bone Resorption
1
2022
302
0.170
Why?
Bone Diseases
1
2021
99
0.170
Why?
Gene Amplification
1
2019
57
0.170
Why?
Recurrence
5
2024
662
0.170
Why?
Atrial Fibrillation
1
2022
183
0.170
Why?
Chromosomal Instability
1
2019
16
0.170
Why?
Gene Regulatory Networks
1
2020
107
0.170
Why?
Hematopoiesis, Extramedullary
1
2019
9
0.170
Why?
Healthcare Disparities
1
2022
268
0.160
Why?
United States
3
2024
4874
0.160
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
10
0.160
Why?
Comorbidity
1
2021
613
0.160
Why?
Sulfonamides
1
2019
128
0.160
Why?
Models, Statistical
1
2020
224
0.160
Why?
Mice
5
2024
5759
0.160
Why?
Spleen
1
2019
172
0.160
Why?
Risk Factors
7
2021
3629
0.160
Why?
Spinal Fractures
1
2018
38
0.160
Why?
Phosphotransferases
1
2018
16
0.160
Why?
Bacteremia
1
2019
92
0.150
Why?
Adipocytes
1
2018
121
0.150
Why?
Cell Differentiation
3
2022
650
0.150
Why?
Gene Rearrangement
1
2018
74
0.150
Why?
Kidney Function Tests
1
2017
49
0.150
Why?
Disease-Free Survival
4
2019
454
0.150
Why?
Hexokinase
1
2017
17
0.150
Why?
Chromosomes, Human, Pair 17
1
2017
36
0.140
Why?
Glomerular Filtration Rate
1
2017
111
0.140
Why?
Calcification, Physiologic
1
2017
41
0.140
Why?
Survival Rate
4
2020
901
0.140
Why?
HIV Infections
1
2021
357
0.140
Why?
Pelvis
1
2017
67
0.140
Why?
Histoplasma
1
2016
27
0.140
Why?
Chromosome Aberrations
2
2023
297
0.140
Why?
CA-125 Antigen
1
2016
17
0.140
Why?
Receptor, TIE-2
1
2016
16
0.140
Why?
Cardiomyopathy, Restrictive
1
2016
5
0.140
Why?
Retrospective Studies
6
2024
6134
0.140
Why?
Animals
7
2024
13246
0.140
Why?
Urea
1
2016
77
0.130
Why?
Histoplasmosis
1
2016
50
0.130
Why?
Indazoles
1
2016
46
0.130
Why?
p38 Mitogen-Activated Protein Kinases
1
2016
96
0.130
Why?
Gene Expression Regulation, Enzymologic
1
2017
180
0.130
Why?
Remission Induction
3
2024
207
0.130
Why?
Tumor Suppressor Protein p53
1
2017
203
0.130
Why?
Gastrointestinal Diseases
1
2016
126
0.130
Why?
Proteasome Inhibitors
1
2016
104
0.120
Why?
Immunologic Factors
1
2016
114
0.120
Why?
Cell Cycle Checkpoints
1
2015
32
0.120
Why?
Kidney Diseases
1
2017
214
0.120
Why?
Time Factors
2
2021
2922
0.120
Why?
Cluster Analysis
1
2015
235
0.120
Why?
Xenograft Model Antitumor Assays
1
2015
212
0.120
Why?
Thrombopoiesis
1
2014
5
0.120
Why?
Myocardium
1
2017
438
0.120
Why?
Hydrazines
1
2014
16
0.120
Why?
Benzoates
1
2014
22
0.120
Why?
Neoplastic Stem Cells
1
2015
103
0.120
Why?
Immunotherapy
1
2016
240
0.110
Why?
Demography
2
2024
92
0.110
Why?
Cystatin M
2
2024
20
0.110
Why?
Cross-Sectional Studies
3
2023
1554
0.110
Why?
Cell Survival
1
2015
602
0.110
Why?
Pyrazoles
1
2014
114
0.110
Why?
Disease Models, Animal
2
2016
1458
0.110
Why?
Chromosomes, Human, Pair 7
1
2012
29
0.100
Why?
Clone Cells
2
2023
78
0.100
Why?
Cardiovascular Diseases
1
2017
443
0.100
Why?
STAT3 Transcription Factor
1
2012
81
0.100
Why?
Chromatin
2
2024
152
0.100
Why?
Cell Transformation, Neoplastic
1
2013
179
0.100
Why?
Follow-Up Studies
3
2024
2190
0.100
Why?
Thalidomide
1
2014
377
0.100
Why?
Flow Cytometry
2
2012
476
0.090
Why?
In Situ Hybridization, Fluorescence
2
2023
259
0.090
Why?
Leukemia, Promyelocytic, Acute
1
2010
11
0.090
Why?
Luciferases
1
2010
50
0.090
Why?
Response Elements
1
2010
29
0.090
Why?
Gene Silencing
1
2010
118
0.090
Why?
Alleles
2
2021
251
0.090
Why?
Tumor Burden
2
2020
131
0.090
Why?
Transfection
1
2010
355
0.080
Why?
Recombinant Fusion Proteins
1
2010
186
0.080
Why?
Molecular Structure
1
2010
296
0.080
Why?
Histones
2
2021
313
0.080
Why?
Apoptosis
2
2014
1112
0.080
Why?
DNA Copy Number Variations
2
2021
110
0.080
Why?
Syndecan-1
2
2021
72
0.080
Why?
Case-Control Studies
2
2024
1126
0.070
Why?
Tumor Cells, Cultured
2
2020
468
0.070
Why?
Imaging, Three-Dimensional
2
2017
153
0.070
Why?
Gene Expression Regulation
1
2010
979
0.060
Why?
Transmembrane Activator and CAML Interactor Protein
1
2024
6
0.060
Why?
Mendelian Randomization Analysis
1
2024
7
0.060
Why?
Telomere
1
2024
36
0.060
Why?
Arkansas
2
2021
1985
0.060
Why?
Mitogen-Activated Protein Kinase Kinases
1
2024
32
0.060
Why?
Killer Cells, Natural
1
2024
107
0.060
Why?
Ferritins
1
2024
30
0.060
Why?
Myeloid Progenitor Cells
1
2023
18
0.060
Why?
X-Ray Microtomography
1
2024
77
0.060
Why?
CD8-Positive T-Lymphocytes
1
2024
128
0.060
Why?
Antibodies
1
2024
154
0.060
Why?
B-Lymphocytes
1
2024
170
0.060
Why?
Receptors, Antigen, T-Cell
1
2023
51
0.060
Why?
Cell Communication
1
2023
69
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Neoplasms
1
2013
1249
0.050
Why?
Patients
1
2022
49
0.050
Why?
Geography
1
2022
60
0.050
Why?
Myeloid Differentiation Factor 88
1
2022
33
0.050
Why?
Patient Selection
1
2023
253
0.050
Why?
United States Food and Drug Administration
1
2022
91
0.050
Why?
Infant
1
2010
3563
0.050
Why?
Oncogenes
1
2021
57
0.050
Why?
Phylogeny
1
2022
234
0.050
Why?
Tomography, X-Ray Computed
2
2017
1161
0.050
Why?
RANK Ligand
1
2022
179
0.050
Why?
SOXC Transcription Factors
1
2021
13
0.050
Why?
Transcriptional Activation
1
2021
121
0.050
Why?
Lymphoma, Large B-Cell, Diffuse
1
2022
106
0.050
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
66
0.050
Why?
Cyclin D2
1
2020
20
0.050
Why?
Aneuploidy
1
2020
16
0.050
Why?
Pyrimidines
1
2022
193
0.050
Why?
Proto-Oncogene Proteins c-maf
1
2020
19
0.050
Why?
Chromosomes, Human, Pair 4
1
2020
31
0.050
Why?
Chromosomes, Human, Pair 11
1
2020
54
0.050
Why?
Histone Code
1
2020
32
0.050
Why?
Cyclin D1
1
2020
56
0.050
Why?
ras Proteins
1
2020
64
0.050
Why?
Genome, Human
1
2021
111
0.050
Why?
Chromosomes, Human, Pair 14
1
2020
75
0.040
Why?
Protein Kinase Inhibitors
1
2022
206
0.040
Why?
DNA, Neoplasm
1
2020
147
0.040
Why?
Health Status Disparities
1
2022
194
0.040
Why?
Genetic Variation
1
2020
213
0.040
Why?
DNA Mutational Analysis
1
2020
176
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2020
170
0.040
Why?
Multivariate Analysis
1
2021
581
0.040
Why?
Osteoclasts
1
2022
428
0.040
Why?
Gram-Positive Bacterial Infections
1
2019
26
0.040
Why?
Computational Biology
1
2020
216
0.040
Why?
Pseudomonas Infections
1
2019
48
0.040
Why?
Syndrome
1
2019
238
0.040
Why?
Randomized Controlled Trials as Topic
1
2021
550
0.040
Why?
Fractures, Compression
1
2018
17
0.040
Why?
Promoter Regions, Genetic
1
2020
475
0.040
Why?
Receptor Protein-Tyrosine Kinases
1
2018
51
0.040
Why?
Protein-Tyrosine Kinases
1
2018
95
0.040
Why?
False Positive Reactions
1
2017
62
0.040
Why?
Bone and Bones
1
2021
475
0.040
Why?
Itraconazole
1
2016
40
0.030
Why?
Amino Acid Sequence
1
2018
586
0.030
Why?
beta-Glucans
1
2016
23
0.030
Why?
Databases, Factual
1
2020
657
0.030
Why?
Alkaline Phosphatase
1
2017
95
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Angiopoietin-1
1
2016
16
0.030
Why?
Amphotericin B
1
2016
110
0.030
Why?
Genes, p53
1
2016
51
0.030
Why?
Ileum
1
2016
87
0.030
Why?
Intestinal Obstruction
1
2016
36
0.030
Why?
NF-kappa B
1
2018
315
0.030
Why?
Colonoscopy
1
2016
92
0.030
Why?
Glycolysis
1
2016
70
0.030
Why?
Gene Knockdown Techniques
1
2016
106
0.030
Why?
Models, Genetic
1
2016
170
0.030
Why?
Genomic Instability
1
2016
93
0.030
Why?
Staphylococcal Infections
1
2019
269
0.030
Why?
Drug Screening Assays, Antitumor
1
2016
140
0.030
Why?
Fever
1
2016
115
0.030
Why?
Image Interpretation, Computer-Assisted
1
2016
106
0.030
Why?
Logistic Models
1
2018
889
0.030
Why?
Phosphatidylinositol 3-Kinases
1
2016
140
0.030
Why?
Heart
1
2017
331
0.030
Why?
Proportional Hazards Models
1
2016
410
0.030
Why?
Algorithms
1
2018
618
0.030
Why?
Echocardiography
1
2017
375
0.030
Why?
Weight Loss
1
2016
238
0.030
Why?
Megakaryocyte Progenitor Cells
1
2014
1
0.030
Why?
Young Adult
1
2024
3981
0.030
Why?
Longitudinal Studies
1
2016
695
0.030
Why?
Antifungal Agents
1
2016
339
0.030
Why?
Models, Immunological
1
2013
8
0.030
Why?
Chemistry, Pharmaceutical
1
2013
33
0.030
Why?
Early Diagnosis
1
2013
87
0.030
Why?
Azacitidine
1
2012
34
0.030
Why?
Karyotyping
1
2012
83
0.030
Why?
Primary Cell Culture
1
2012
61
0.030
Why?
Cell Lineage
1
2012
84
0.030
Why?
Polymerase Chain Reaction
1
2013
454
0.020
Why?
Child
1
2024
6851
0.020
Why?
Antigens, CD
1
2012
221
0.020
Why?
Enzyme Inhibitors
1
2013
386
0.020
Why?
Magnetic Resonance Imaging
1
2017
1541
0.020
Why?
Cytokines
1
2013
613
0.020
Why?
Reproducibility of Results
1
2013
1185
0.020
Why?
Cohort Studies
1
2013
1422
0.020
Why?
Schinke's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description